See here for a summary of what we know about the gut-liver axis and the companies pursuing microbiome-focused therapies for liver disease:
https://t.co/2tHlSCUUlx
Happening now!
The FDA's Vaccines and Related Biological Products Advisory Committee is about to vote on the Biologics License Application from Rebiotix Inc. for its live fecal microbiota product, Rebyota.
https://t.co/NHxx90dP0N
Check out this FREE event from Naturally Informed -- Microbiome: Mastering the Market.
Industry members have the opportunity to learn about the latest science & best practices for communicating about the microbiome.
https://t.co/fBJ5TNlyEl
Panel will cover what the microbiome field can learn from another field of pharma innovation -- advanced therapy medicinal products:
https://t.co/RfPwKF3rfL
New results, which herald the first instance of a microbiome company advancing to a Phase 3 trial for a dermatology application:
https://t.co/04KoHRhiWd
Get up to speed on the patent dispute between two of the microbiome companies with leading live biotherapeutic products for recurrent C. difficile infection:
https://t.co/9Tc50ft61x
Agriculture in the US has mainly focused on yield, sustainability, and providing good value to the consumer.
But what if growing foods for HEALTH became a driver of agricultural innovation? Profs. Andy Benson & Bruce German share their vision here:
https://t.co/8vNmCer3Rc
Tiffany Weir: microbiome modulation has great potential for addressing disease and it's an active area of research, so why don't we have more microbiome-targeting therapies? She argues prevention may be the most promising approach.
#AgHealthSummit
Regulation of food for health (including probiotics & prebiotics) is a hot topic -- learn more in our panel discussion on October 12th!
Register here:
https://t.co/P31RviXfXD
Have you wondered about the best path to commercialization for your microbiome-focused product?
Dr. Eileen Murphy will lead a discussion on all aspects of commercialization -- from science to funding to communications to legal.
Sign up here to tune in:
https://t.co/P31RviXfXD